DENTSPLY SIRONA (NASDAQ: XRAY) director gets 198 RSU dividend units

Q: What did DENTSPLY SIRONA (XRAY) disclose in this Form 4 filing?

The filing shows that director Leslie F. Varon acquired 198.141 shares of common stock on 01/09/2026 , received as dividend-equivalent restricted stock units (RSUs) at a price of $0 per share.

Q: Who is the insider involved in the DENTSPLY SIRONA (XRAY) Form 4?

The reporting person is Leslie F. Varon , who is listed as a director of DENTSPLY SIRONA Inc. and filed the Form 4 as a single reporting person.

Q: How many DENTSPLY SIRONA shares does the director own after this transaction?

Following the reported acquisition, Leslie F. Varon directly beneficially owned 57,541.066 shares of DENTSPLY SIRONA common stock.

Q: What type of shares were acquired in this DENTSPLY SIRONA Form 4?

The transaction involved common stock , received as dividend-equivalent restricted stock units (RSUs) that convert into common stock on a 1:1 basis .

Q: How were the 198.141 DENTSPLY SIRONA RSUs granted to the director?

According to the footnote, the 198.141 RSUs represent dividends on existing RSUs , credited as additional RSUs and subject to the same vesting terms as the underlying awards.

Q: When do the dividend-equivalent RSUs in this DENTSPLY SIRONA filing vest?

The filing states that the dividend-equivalent RSUs vest simultaneously with the RSUs to which they relate, following the same vesting schedule as the original awards.

Q: Does the DENTSPLY SIRONA director hold these shares directly or indirectly?

The Form 4 indicates the ownership form as Direct (D) , meaning the 57,541.066 shares after the transaction are held directly by Leslie F. Varon .

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

DENTSPLY SIRONA Inc. director Leslie F. Varon reported an acquisition of company equity tied to existing restricted stock units (RSUs). On 01/09/2026, Varon received 198.141 shares of common stock at a price of $0, reflecting dividends on previously granted RSUs that were paid in the form of additional RSUs. These dividend-equivalent RSUs carry the same vesting terms as the underlying awards and will vest at the same time. After this transaction, Varon directly beneficially owned 57,541.066 shares of DENTSPLY SIRONA common stock.

Insider Trade Summary

Net Buyer: 198.141 shares

Net Buy 1 txn

Insider VARON LESLIE F

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	198.141	$0.00	$0.00

Holdings After Transaction: Common Stock — 57,541.066 shares (Direct)

Footnotes (1)

F1. Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.

FAQ

What did DENTSPLY SIRONA (XRAY) disclose in this Form 4 filing?

The filing shows that director Leslie F. Varon acquired 198.141 shares of common stock on 01/09/2026, received as dividend-equivalent restricted stock units (RSUs) at a price of $0 per share.

Who is the insider involved in the DENTSPLY SIRONA (XRAY) Form 4?

The reporting person is Leslie F. Varon, who is listed as a director of DENTSPLY SIRONA Inc. and filed the Form 4 as a single reporting person.

How many DENTSPLY SIRONA shares does the director own after this transaction?

Following the reported acquisition, Leslie F. Varon directly beneficially owned 57,541.066 shares of DENTSPLY SIRONA common stock.

What type of shares were acquired in this DENTSPLY SIRONA Form 4?

The transaction involved common stock, received as dividend-equivalent restricted stock units (RSUs) that convert into common stock on a 1:1 basis.

How were the 198.141 DENTSPLY SIRONA RSUs granted to the director?

According to the footnote, the 198.141 RSUs represent dividends on existing RSUs, credited as additional RSUs and subject to the same vesting terms as the underlying awards.

When do the dividend-equivalent RSUs in this DENTSPLY SIRONA filing vest?

The filing states that the dividend-equivalent RSUs vest simultaneously with the RSUs to which they relate, following the same vesting schedule as the original awards.

Does the DENTSPLY SIRONA director hold these shares directly or indirectly?

The Form 4 indicates the ownership form as Direct (D), meaning the 57,541.066 shares after the transaction are held directly by Leslie F. Varon.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 01/13/2026 - 04:38 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

VARON LESLIE F

(Last)

(First)

(Middle)

C/O DENTSPLY SIRONA INC

13320-B BALLANTYNE CORPORATE PLACE

(Street)

CHARLOTTE

28277

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
DENTSPLY SIRONA Inc. [ XRAY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	01/09/2026		A		198.141⁽¹⁾	A	$0	57,541.066	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.

	/s/ Jessica Nielsen Causey, Attorney-in-Fact for Leslie F. Varon	01/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR